Treatment
-
The Survival GapIn the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Clinical Trials Game-Changer?A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?
by Sue Rochman
-
Cancer In America
Standard of CareResearch suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?
by Charlotte Huff
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
-
Forward Look
The Avastin Roller CoasterUps and downs keep coming for Avastin as studies report on its effects for different cancers.
by Sue Rochman
-
Forward Look
Boosting Defenses Against CancerQ&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.
by Ingfei Chen
-
Forward Look
Second-Cancer Clues?Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.
by Mitzi Baker
-
Forward Look
Getting PersonalHealth care experts push for care that focuses on the patient.
by Alanna Kennedy-Gorman
-
Forward Look
Avastin’s FateDebate goes on as FDA revokes drug's use for breast cancer.
by Alanna Kennedy-Gorman
-
Staying the CoursePatients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.
by Melissa Weber
